Discovery & history

• How GHK-Cu was discovered in 1973 and what it actually is
• The copper-carrier and cuproenzyme mechanisms behind its repair reputation
• How to read the skin, hair, wound, and gene-expression evidence tier by tier
• How to think critically about delivery, dosing claims, and copper safety

1. 01 Discovery & history The tripeptide that ties copper to skin and wound biology free
2. 02 The molecule and its copper chelate Three amino acids that grip a single copper ion paid
3. 03 How it works: the copper-carrier model Delivering copper to the enzymes that build and protect tissue paid
4. 04 How it works: inflammation and matrix remodeling Tuning inflammation and rebuilding the matrix paid
5. 05 The gene-expression data The "resets gene expression" data, read carefully paid
6. 06 Skin and cosmetic evidence The largest body of human evidence GHK-Cu has paid
7. 07 Hair-growth signals A weaker hair story than the marketing suggests paid
8. 08 Wound healing Moderate evidence, from one human trial and many animals paid
9. 09 Delivery, dosing & administration How GHK-Cu is prepared and administered paid
10. 10 The research frontier Where GHK-Cu is being studied next paid
11. 11 Safety & side effects What we know about GHK-Cu safety, and what we do not paid
12. 12 Final exam & certification Pass the final exam to earn your certificate of completion. Exam

Pickart’s pivotal experiment was elegantly simple: he bathed old human liver tissue in plasma from young donors and watched what changed. A caution belongs here before anything else. The 1973 paper carries no abstract, so the experiment reaches us through its title and a later review’s retelling, which describes plasma from young individuals causing old liver tissue to produce proteins more characteristic of younger individuals. Donor ages, the proteins measured and the size of the effect are not readable anywhere in the fetched record.

Nothing was added to the old tissue except young plasma, so whatever caused the change had to be a substance already circulating in young blood. That single inference turned a curious observation into a hunt for one molecule, whose sequence was published in 1977.

More than four decades separate the 1973 serum report from the 2018 gene-data review, and the major beats below run from that first report to the modern gene-expression work.

What stands out is how slowly the real picture filled in. The early fibroblast work showed GHK-Cu could stimulate collagen synthesis in culture, but the reviews that pulled the scattered cell, animal and small human studies into one story came decades later, and the 2014, 2015 and 2018 reviews this course draws on all have Pickart, the first author of the 1973 paper, as their first author.

Strip away the hype and GHK-Cu is just three amino acids in a row, carrying a single copper ion. The bare peptide occurs naturally in human plasma and has been measured there. Whether that level falls with age, which is the premise most marketing is built on, is a separate question the unit on chemistry takes apart.

In solution the copper is held by two or three nitrogen atoms, and electron spin-echo work places one of them in the histidine ring; the chemistry unit takes the rest of the copper site apart. Take the copper away and the bare peptide still signals. Which of the two is doing the work is genuinely unsettled: one fibroblast study found its effect came from copper ions and not from the peptide, while keratinocyte work found copper-free GHK did much of what the complex did.

Before any mechanisms, the honest picture: what is actually well supported versus merely hopeful. Keeping these tiers apart is the whole point of this course, because the marketing tends to round everything up to proven. The pattern repeats at every level: a real but modest finding in cells or a small study gets restated online as a settled human result. Sorting each claim into solid, moderate, weak, or missing is the habit this page is training.

A few specific claims you will see online, held against the evidence above. Notice the pattern: most are not flatly false, they are real but modest findings rounded up into certainty.

Reading each claim against its actual evidence tier is exactly the skill this course is built to give you. By the final exam, you should be able to take any GHK-Cu marketing sentence and place it on this map yourself.

GHK is not foreign to the body. It circulates in plasma and is also liberated when certain matrix proteins break down, which is why researchers describe it as a natural signal that injury releases on site.

This framing matters: if GHK is a repair signal the body releases on site, then supplying it is conceptually replacement rather than adding something alien. That logic is appealing, but it is a rationale for studying GHK-Cu, not proof that topping it up restores youthful repair in people. The replacement story usually adds that supply falls with age, and that half is not supported by anything measured.